{"id":7832,"date":"2025-07-03T14:32:17","date_gmt":"2025-07-03T11:32:17","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=7832"},"modified":"2025-07-03T14:32:17","modified_gmt":"2025-07-03T11:32:17","slug":"surgical-valve-innovation-vs-transcatheter-growth","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/surgical-valve-innovation-vs-transcatheter-growth\/","title":{"rendered":"Surgical Valve Innovation vs Transcatheter Growth"},"content":{"rendered":"<div>Surgical Valve Innovation vs Transcatheter Growth<\/div>\n<div><\/div>\n<div>Source: Journal of the American College of Cardiology \u2013 June 27, 2025<\/div>\n<div><\/div>\n<div><span> 1. Surgical heart valve innovation has slowed down, while transcatheter treatments (like TAVR) are developing quickly.<\/span><\/div>\n<div><span> 2. Surgeons say surgery still has advantages, like long-term results and precise repairs, but it\u2019s more invasive.<\/span><\/div>\n<div><span> 3. New surgical devices are rare\u2014the Tria polymer valve is a recent example, but most progress stopped years ago.<\/span><\/div>\n<div><span> 4. Why the slowdown?<\/span><\/div>\n<div><span> \u2022 Surgical valves work well, so few push for change<\/span><\/div>\n<div><span> \u2022 Surgeons tend to stick to proven methods<\/span><\/div>\n<div><span> \u2022 Less industry funding for surgical research<\/span><\/div>\n<div><span> 5. Transcatheter options get more attention, but surgery may still be better for younger, low-risk patients who want lasting solutions.<\/span><\/div>\n<div><span> 6. The authors call for:<\/span><\/div>\n<div><span> \u2022 Better data and clinical trials in surgery<\/span><\/div>\n<div><span> \u2022 More funding to bring back innovation in surgical valves<\/span><\/div>\n<div><span> 7. The goal is to balance both approaches\u2014surgical and transcatheter\u2014to give patients the best, long-term care.<\/span><\/div>\n<div><\/div>\n<div>https:\/\/www.jacc.org\/doi\/10.1016\/j.jacc.2025.06.024<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Surgical Valve Innovation vs Transcatheter Growth Source: Journal of the American College of Cardiology \u2013 June 27, 2025 1. Surgical heart valve innovation has slowed down, while transcatheter treatments (like TAVR) are developing quickly. 2. Surgeons say surgery still has advantages, like long-term results and precise repairs, but it\u2019s more invasive. 3. New surgical devices [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7832","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7832","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=7832"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7832\/revisions"}],"predecessor-version":[{"id":7833,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7832\/revisions\/7833"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=7832"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=7832"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=7832"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}